{"title":"[3H]胆固醇标记脂质体与吡喹酮或不含吡喹酮感染小鼠四甲状腺病的分布","authors":"Gabriela Hrčkova, Samuel Velebny, Michal Giboda","doi":"10.1016/S0742-8413(00)00109-2","DOIUrl":null,"url":null,"abstract":"<div><p>The anthelmintic drug praziquantel (PZQ) has a short half-life in the circulation, necessitating repeated daily administration of PZQ for the therapy of larval stages of cestodes. The effect of incorporation of PZQ into multilamellar liposomes on their biodistribution in <em>Mesocestoides corti</em> (syn. <em>M. vogae</em>) infected mice has been examined using [<sup>3</sup>H]cholesterol as a liposomal marker. Incorporation of PZQ significantly increased the average size of liposomes with 70.3% of [<sup>3</sup>H]lip.PZQ particles up to 1.9 μm, whereas higher portion of [<sup>3</sup>H]liposomes (66.3% of total) were of smaller (up to 1.3 μm). Both liposome preparations were given intraperitoneally to avoid rapid sequestration in the liver. There were significant differences between [<sup>3</sup>H]liposomes and [<sup>3</sup>H]lip.PZQ-associated radioactivity in peritoneal adherent cells, liver- and peritoneal larvae, liver, spleen and lymph nodes within 16 days of examination. The highest uptake (about 2-fold more [<sup>3</sup>H]lip.PZQ than [<sup>3</sup>H]liposomes from the total dose) was found in peritoneal cells on day 1 post therapy (p.t.) followed by a rapid decline. The kinetic of decline in these cells recovered on day 1 p.t. was studied also in vitro. Disappearance of the marker due to the breakdown of liposomes and efflux of lipids and PZQ from cells was slower for [<sup>3</sup>H]lip.PZQ in comparison with drug-free liposomes and was not completed after 4 days-incubation. Significantly increased levels of radioactivity, more in [<sup>3</sup>H]liposomes treated groups, were recorded in the liver- and peritoneal larvae between days 8–16 p.t. indicating re-utilization of cholesterol by the larvae. The data suggest that incorporation of PZQ into liposomes contributes to the enlargement of liposome average size and slows down their degradation in phagocytosing cells. In this respect, these cells could serve as the secondary circulating depots for PZQ releasing it slowly to the circulation.</p></div>","PeriodicalId":10586,"journal":{"name":"Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2000-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0742-8413(00)00109-2","citationCount":"6","resultStr":"{\"title\":\"Distribution of [3H]cholesterol-labelled liposomes with or without praziquantel in mice infected with Mesocestoides corti (Cestoda) tetrathyridia\",\"authors\":\"Gabriela Hrčkova, Samuel Velebny, Michal Giboda\",\"doi\":\"10.1016/S0742-8413(00)00109-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The anthelmintic drug praziquantel (PZQ) has a short half-life in the circulation, necessitating repeated daily administration of PZQ for the therapy of larval stages of cestodes. The effect of incorporation of PZQ into multilamellar liposomes on their biodistribution in <em>Mesocestoides corti</em> (syn. <em>M. vogae</em>) infected mice has been examined using [<sup>3</sup>H]cholesterol as a liposomal marker. Incorporation of PZQ significantly increased the average size of liposomes with 70.3% of [<sup>3</sup>H]lip.PZQ particles up to 1.9 μm, whereas higher portion of [<sup>3</sup>H]liposomes (66.3% of total) were of smaller (up to 1.3 μm). Both liposome preparations were given intraperitoneally to avoid rapid sequestration in the liver. There were significant differences between [<sup>3</sup>H]liposomes and [<sup>3</sup>H]lip.PZQ-associated radioactivity in peritoneal adherent cells, liver- and peritoneal larvae, liver, spleen and lymph nodes within 16 days of examination. The highest uptake (about 2-fold more [<sup>3</sup>H]lip.PZQ than [<sup>3</sup>H]liposomes from the total dose) was found in peritoneal cells on day 1 post therapy (p.t.) followed by a rapid decline. The kinetic of decline in these cells recovered on day 1 p.t. was studied also in vitro. Disappearance of the marker due to the breakdown of liposomes and efflux of lipids and PZQ from cells was slower for [<sup>3</sup>H]lip.PZQ in comparison with drug-free liposomes and was not completed after 4 days-incubation. Significantly increased levels of radioactivity, more in [<sup>3</sup>H]liposomes treated groups, were recorded in the liver- and peritoneal larvae between days 8–16 p.t. indicating re-utilization of cholesterol by the larvae. The data suggest that incorporation of PZQ into liposomes contributes to the enlargement of liposome average size and slows down their degradation in phagocytosing cells. In this respect, these cells could serve as the secondary circulating depots for PZQ releasing it slowly to the circulation.</p></div>\",\"PeriodicalId\":10586,\"journal\":{\"name\":\"Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2000-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0742-8413(00)00109-2\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0742841300001092\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0742841300001092","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6
摘要
驱虫药吡喹酮(PZQ)在循环中的半衰期短,需要每天重复服用吡喹酮来治疗幼虫期的蛔虫。用[3H]胆固醇作为脂质体标记物,研究了PZQ掺入多层脂质体对其在corti Mesocestoides (syn. M. vogae)感染小鼠体内生物分布的影响。PZQ的加入显著增加了脂质体的平均大小,达到[3H]唇的70.3%。PZQ颗粒最大达1.9 μm,而[3H]脂质体较小(最大达1.3 μm)的比例较高(66.3%)。两种脂质体制剂均腹腔内给药,以避免在肝脏中快速隔离。[3H]脂质体与[3H]唇有显著性差异。检查后16天内腹膜贴壁细胞、肝脏和腹膜幼虫、肝脏、脾脏和淋巴结的pzq相关放射性。最高摄取量(约2倍以上[3H]唇。PZQ比[3H]脂质体(总剂量)在治疗后第1天(p.t)在腹膜细胞中发现,随后迅速下降。在体外研究了这些细胞在第1天恢复的衰退动力学。在[3H]lip中,由于脂质体的分解和脂质和PZQ从细胞外排而导致标记物消失的速度较慢。PZQ与无药脂质体比较,孵育4天后未完成。在第8-16天,肝脏和腹膜幼虫的放射性水平显著升高,[3H]脂质体处理组的放射性水平更高,表明幼虫对胆固醇的再利用。这些数据表明,PZQ掺入脂质体有助于增加脂质体的平均大小,减缓其在吞噬细胞中的降解。在这方面,这些细胞可以作为PZQ的二级循环库,将其缓慢地释放到循环中。
Distribution of [3H]cholesterol-labelled liposomes with or without praziquantel in mice infected with Mesocestoides corti (Cestoda) tetrathyridia
The anthelmintic drug praziquantel (PZQ) has a short half-life in the circulation, necessitating repeated daily administration of PZQ for the therapy of larval stages of cestodes. The effect of incorporation of PZQ into multilamellar liposomes on their biodistribution in Mesocestoides corti (syn. M. vogae) infected mice has been examined using [3H]cholesterol as a liposomal marker. Incorporation of PZQ significantly increased the average size of liposomes with 70.3% of [3H]lip.PZQ particles up to 1.9 μm, whereas higher portion of [3H]liposomes (66.3% of total) were of smaller (up to 1.3 μm). Both liposome preparations were given intraperitoneally to avoid rapid sequestration in the liver. There were significant differences between [3H]liposomes and [3H]lip.PZQ-associated radioactivity in peritoneal adherent cells, liver- and peritoneal larvae, liver, spleen and lymph nodes within 16 days of examination. The highest uptake (about 2-fold more [3H]lip.PZQ than [3H]liposomes from the total dose) was found in peritoneal cells on day 1 post therapy (p.t.) followed by a rapid decline. The kinetic of decline in these cells recovered on day 1 p.t. was studied also in vitro. Disappearance of the marker due to the breakdown of liposomes and efflux of lipids and PZQ from cells was slower for [3H]lip.PZQ in comparison with drug-free liposomes and was not completed after 4 days-incubation. Significantly increased levels of radioactivity, more in [3H]liposomes treated groups, were recorded in the liver- and peritoneal larvae between days 8–16 p.t. indicating re-utilization of cholesterol by the larvae. The data suggest that incorporation of PZQ into liposomes contributes to the enlargement of liposome average size and slows down their degradation in phagocytosing cells. In this respect, these cells could serve as the secondary circulating depots for PZQ releasing it slowly to the circulation.